Heartburn resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 1: Line 1:
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0";
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0" ;
|-
|-
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align=center| {{fontcolor|#2B3B44|Heartburn Resident Survival Guide Microchapters}}
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align="center" |{{fontcolor|#2B3B44|Heartburn Resident Survival Guide Microchapters}}
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Heartburn resident survival guide#Overview|Overview]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heartburn resident survival guide#Overview|Overview]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Heartburn resident survival guide#Causes|Causes]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heartburn resident survival guide#Causes|Causes]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Heartburn resident survival guide#Diagnosis|Diagnosis]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heartburn resident survival guide#Diagnosis|Diagnosis]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Heartburn resident survival guide#Treatment|Treatment]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heartburn resident survival guide#Treatment|Treatment]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Heartburn resident survival guide#Do's|Do's]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heartburn resident survival guide#Do's|Do's]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Heartburn resident survival guide#Don'ts|Don'ts]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heartburn resident survival guide#Don'ts|Don'ts]]
|}
|}


Line 34: Line 34:
{| class="wikitable"
{| class="wikitable"
|+Differentiating heartburn from angina <ref name="urlHeartburn vs. heart attack - Harvard Health">{{cite web |url=https://www.health.harvard.edu/heart-health/heartburn-vs-heart-attack/heart-health/heartburn-vs-heart-attack/heart-health/heartburn-vs-heart-attack |title=Heartburn vs. heart attack - Harvard Health |format= |work= |accessdate=}}</ref> <ref name="pmid20003376">{{cite journal| author=Bösner S, Haasenritter J, Becker A, Hani MA, Keller H, Sönnichsen AC | display-authors=etal| title=Heartburn or angina? Differentiating gastrointestinal disease in primary care patients presenting with chest pain: a cross sectional diagnostic study. | journal=Int Arch Med | year= 2009 | volume= 2 | issue=  | pages= 40 | pmid=20003376 | doi=10.1186/1755-7682-2-40 | pmc=2799444 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20003376  }} </ref>
|+Differentiating heartburn from angina <ref name="urlHeartburn vs. heart attack - Harvard Health">{{cite web |url=https://www.health.harvard.edu/heart-health/heartburn-vs-heart-attack/heart-health/heartburn-vs-heart-attack/heart-health/heartburn-vs-heart-attack |title=Heartburn vs. heart attack - Harvard Health |format= |work= |accessdate=}}</ref> <ref name="pmid20003376">{{cite journal| author=Bösner S, Haasenritter J, Becker A, Hani MA, Keller H, Sönnichsen AC | display-authors=etal| title=Heartburn or angina? Differentiating gastrointestinal disease in primary care patients presenting with chest pain: a cross sectional diagnostic study. | journal=Int Arch Med | year= 2009 | volume= 2 | issue=  | pages= 40 | pmid=20003376 | doi=10.1186/1755-7682-2-40 | pmc=2799444 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20003376  }} </ref>
! align="center" style="background: #4479BA; color: #FFFFFF |Heartburn (GERD)
! align="center" style="background: #4479BA; color: #FFFFFF " |Heartburn (GERD)
! align="center" style="background: #4479BA; color: #FFFFFF |Angina or Heart Attack
! align="center" style="background: #4479BA; color: #FFFFFF " |Angina or Heart Attack
|-
|-
|Burning [[chest pain]], begins at the [[breastbone]]
|Burning [[chest pain]], begins at the [[breastbone]]
Line 72: Line 72:
The diagnosis of [[GERD]] is made based on:  
The diagnosis of [[GERD]] is made based on:  


* Symptom presentation;
*Symptom presentation;
* Response to antisecretory therapy;
*Response to antisecretory therapy;
* Objective testing with [[endoscopy]];
*Objective testing with [[endoscopy]];
* Ambulatory reflux monitoring.<ref name="pmid23419381" />
*Ambulatory reflux monitoring.<ref name="pmid23419381" />


<br>
<br>
Line 111: Line 111:
{{familytree/end}}
{{familytree/end}}


* High Risk: Men >50 years with chronic [[gastroesophageal reflux disease]] symptoms (>5 years), AND:  
*High Risk: Men >50 years with chronic [[gastroesophageal reflux disease]] [[symptoms]] (>5 years), AND:  
** Nocturnal reflux symptoms,
**[[Nocturnal]] [[reflux]] [[symptoms]]
**[[Hiatal hernia]],
**[[Hiatal hernia]]
** Elevated body mass index,
**Elevated [[body mass index]]
**[[Tobacco]] use,
**[[Tobacco]] use
** Intra-abdominal distribution of fat.
**Intra-abdominal distribution of fat


Perform [[upper endoscopy]] to detect [[esophageal adenocarcinoma]] and [[Barret’s esophagus]]. Surveillance examinations should occur not more frequently than once every 3 to 5 years. If the patient presents with [[Barret's Esophagus|Barret's]] [[esophagus]] or [[dysplasia]], more frequent intervals are indicated. <ref name="urlwww.worldgastroenterology.org">{{cite web |url=https://www.worldgastroenterology.org/UserFiles/file/WDHD-2015-handbook-final.pdf |title=www.worldgastroenterology.org |format= |work= |accessdate=}}</ref>
Perform [[upper endoscopy]] to detect [[esophageal adenocarcinoma]] and [[Barret’s esophagus]]. Surveillance examinations should occur not more frequently than once every 3 to 5 years. If the [[patient]] presents with [[Barret's Esophagus|Barret's]] [[esophagus]] or [[dysplasia]], more frequent intervals are indicated. <ref name="urlwww.worldgastroenterology.org">{{cite web |url=https://www.worldgastroenterology.org/UserFiles/file/WDHD-2015-handbook-final.pdf |title=www.worldgastroenterology.org |format= |work= |accessdate=}}</ref>


Screening for [[H. Pylori]] is not recommended routinely on [[GERD]]. <ref name="urlwww.worldgastroenterology.org">{{cite web |url=https://www.worldgastroenterology.org/UserFiles/file/WDHD-2015-handbook-final.pdf |title=www.worldgastroenterology.org |format= |work= |accessdate=}}</ref>
Screening for [[H. Pylori]] is not recommended routinely on [[GERD]]. <ref name="urlwww.worldgastroenterology.org">{{cite web |url=https://www.worldgastroenterology.org/UserFiles/file/WDHD-2015-handbook-final.pdf |title=www.worldgastroenterology.org |format= |work= |accessdate=}}</ref>
{| class="wikitable"
{| class="wikitable"
|+Diagnostic Testing for GERD <ref name="pmid23419381">{{cite journal| author=Katz PO, Gerson LB, Vela MF| title=Guidelines for the diagnosis and management of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2013 | volume= 108 | issue= 3 | pages= 308-28; quiz 329 | pmid=23419381 | doi=10.1038/ajg.2012.444 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23419381  }} </ref> <ref name="pmid28631728">{{cite journal| author=Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N| title=ACG and CAG Clinical Guideline: Management of Dyspepsia. | journal=Am J Gastroenterol | year= 2017 | volume= 112 | issue= 7 | pages= 988-1013 | pmid=28631728 | doi=10.1038/ajg.2017.154 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28631728  }} </ref>
|+Diagnostic Testing for GERD <ref name="pmid23419381">{{cite journal| author=Katz PO, Gerson LB, Vela MF| title=Guidelines for the diagnosis and management of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2013 | volume= 108 | issue= 3 | pages= 308-28; quiz 329 | pmid=23419381 | doi=10.1038/ajg.2012.444 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23419381  }} </ref> <ref name="pmid28631728">{{cite journal| author=Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N| title=ACG and CAG Clinical Guideline: Management of Dyspepsia. | journal=Am J Gastroenterol | year= 2017 | volume= 112 | issue= 7 | pages= 988-1013 | pmid=28631728 | doi=10.1038/ajg.2017.154 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28631728  }} </ref>
! align="center" style="background: #4479BA; color: #FFFFFF |Test
! align="center" style="background: #4479BA; color: #FFFFFF " |Test
! align="center" style="background: #4479BA; color: #FFFFFF |Indication
! align="center" style="background: #4479BA; color: #FFFFFF " |Indication
! align="center" style="background: #4479BA; color: #FFFFFF |Recommendation
! align="center" style="background: #4479BA; color: #FFFFFF " |Recommendation
|-
|-
|[[Proton Pump Inhibitor]] ([[PPI]]) trial
|[[Proton Pump Inhibitor]] ([[PPI]]) trial
|Classic symptoms, no warning/alarm symptoms
|Classic [[symptoms]], no warning/alarm [[symptoms]]
|If negative does not rule out [[GERD]]
|If negative does not rule out [[GERD]]
|-
|-
|[[Barium swallow]]
|[[Barium swallow]]
|Use for evaluating [[dysphagia]]
|Use for evaluating [[dysphagia]]
|Only useful for complications ([[stricture]], ring)
|Only useful for [[complications]] ([[stricture]], ring)
|-
|-
|[[Endoscopy]]
|[[Endoscopy]]
|Use if alarm symptoms, chest pain or high risk* patients
|Use if alarm [[symptoms]], [[chest pain]] or high risk* [[patients]]
|Consider early for elderly, high risk for [[Barret’s esophagus|Barret’s,]] non-cardiac [[chest pain]], patients unresponsive to PPI
|Consider early for elderly, high risk for [[Barret’s esophagus|Barret’s,]] non-cardiac [[chest pain]], patients unresponsive to PPI
|-
|-
|Esophageal [[biopsy]]
|[[Esophageal]] [[biopsy]]
|Exclude non-GERD causes
|Exclude non-GERD causes
|
|
|-
|-
|Esophageal [[manometry]]
|[[Esophageal]] [[manometry]]
|Pre operative evaluation for surgery
|Pre operative evaluation for [[surgery]]
|Rule out [[achalasia]]/[[scleroderma]]-like esophagus pre-op
|Rule out [[achalasia]]/[[scleroderma]]-like esophagus pre-op
|-
|-
|Ambulatory reflux monitoring
|Ambulatory reflux monitoring
|Preoperatively for non-erosive disease, refractory [[GERD]] symptoms or [[GERD]] diagnosis in question
|Preoperatively for non-erosive disease, refractory [[GERD]] [[symptoms]] or [[GERD]] [[diagnosis]] in question
|Correlate symptoms with reflux, document abnormal acid exposure or reflux frequency
|Correlate [[symptoms]] with reflux, document abnormal acid exposure or reflux frequency
|}
|}


Line 155: Line 155:
Shown below is an algorithm summarizing the treatment of refractory [[GERD]] according the the American Journal of Gastroenterology guidelines.<ref name="pmid23419381">{{cite journal| author=Katz PO, Gerson LB, Vela MF| title=Guidelines for the diagnosis and management of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2013 | volume= 108 | issue= 3 | pages= 308-28; quiz 329 | pmid=23419381 | doi=10.1038/ajg.2012.444 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23419381  }} </ref>
Shown below is an algorithm summarizing the treatment of refractory [[GERD]] according the the American Journal of Gastroenterology guidelines.<ref name="pmid23419381">{{cite journal| author=Katz PO, Gerson LB, Vela MF| title=Guidelines for the diagnosis and management of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2013 | volume= 108 | issue= 3 | pages= 308-28; quiz 329 | pmid=23419381 | doi=10.1038/ajg.2012.444 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23419381  }} </ref>


Lifestyle modifications are indicated for all patients and include:
Lifestyle modifications are indicated for all [[patients]] and include:


* Dietary changes (reduce ingestion of [[chocolate]], [[caffeine]], [[alcohol]], acidic and/or spicy foods - low degree of evidence, but there are reports of improvements with elimination);
*Dietary changes (reduce ingestion of [[chocolate]], [[caffeine]], [[alcohol]], acidic and/or spicy foods - low degree of evidence, but there are reports of improvements with elimination);
*[[Weight loss]] for overweight patients or patients that have had recent weight gain;
*[[Weight loss]] for overweight patients or patients that have had recent weight gain;
*Head of bed elevation and avoidance of meals 2–3 h before bedtime if nocturnal symptoms.<ref name="pmid23419381" />
*Head of bed elevation and avoidance of meals 2–3 h before bedtime if nocturnal symptoms.<ref name="pmid23419381" />
Line 163: Line 163:
{| class="wikitable"
{| class="wikitable"
|+Medications used in GERD
|+Medications used in GERD
! align="center" style="background: #4479BA; color: #FFFFFF |Medication
! align="center" style="background: #4479BA; color: #FFFFFF " |Medication
! align="center" style="background: #4479BA; color: #FFFFFF |Indication
! align="center" style="background: #4479BA; color: #FFFFFF " |Indication
! align="center" style="background: #4479BA; color: #FFFFFF |Recommendation
! align="center" style="background: #4479BA; color: #FFFFFF " |Recommendation
|-
|-
|[[Proton pump inhibitor|PPI]] therapy
|[[Proton pump inhibitor|PPI]] therapy
|All patients without contraindications
|All [[patients]] without contraindications
|Use the lowest effective dose, safe during [[pregnancy]]
|Use the lowest effective dose, safe during [[pregnancy]]
|-
|-
|[[H2-receptor antagonist]]
|[[H2-receptor antagonist]]
|May be used as a complement to PPIs or as maintenance option in patients without erosive disease
|May be used as a complement to [[PPI|PPIs]] or as maintenance option in patients without erosive disease
|Beware [[tachyphylaxis]] after several weeks of usage
|Beware [[tachyphylaxis]] after several weeks of usage
|-
|-
|[[Prokinetic]] therapy and/or [[baclofen]]
|[[Prokinetic]] therapy and/or [[baclofen]]
|Used if symptoms do not improve
|Used if [[symptoms]] do not improve
|Undergo diagnostic evaluation first
|Undergo [[diagnostic]] evaluation first
|-
|-
|[[Sucralfate]]
|[[Sucralfate]]
Line 185: Line 185:
<br />
<br />


== Do's==
==Do's==


*
*
*Differentiate [[heartburn]] from cardiac [[chest pain]];
*Differentiate [[heartburn]] from cardiac [[chest pain]];
*Consider a twice daily dosing in patients with night-time symptoms, variable schedules, and/or [[sleep disturbance]];
*Consider a twice daily dosing in patients with night-time symptoms, variable schedules, and/or [[sleep disturbance]];
*Advise the patient to cease eating [[chocolate]], [[caffeine]], spicy foods, [[citrus]] or carbonated beverages;
*Advise the [[patient]] to cease eating [[chocolate]], [[caffeine]], spicy foods, [[citrus]] or carbonated beverages;
*Strongly recommend [[weight loss]] if patient's BMI is >25 or recent [[weight gain]];
*Strongly recommend [[weight loss]] if patient's BMI is higher than 25 or recent [[weight gain]];
*Recommend head of bed elevation if nocturnal [[GERD]];
*Recommend head of bed elevation if [[nocturnal]] [[GERD]];
*Advise against late evening meals;
*Advise against late evening meals;
*Promote [[alcohol]] and [[tobacco]] cessation.
*Promote [[alcohol]] and [[tobacco]] cessation.
*If there is an alarm symptom such as [[dysphagia]]
*If there is an alarm [[Symptoms|symptom]] such as [[dysphagia]].
*If there's no response with such measures and initial 8-week [[PPI]] treatment, refer patient to a specialist.
*If there's no response with such measures and initial 8-week [[PPI]] treatment, refer [[patient]] to a specialist.


==Don'ts ==
==Don'ts==


*Do not request an [[upper endoscopy]] for every patient complaining of [[GERD]];
*Do not request an [[upper endoscopy]] for every [[patient]] complaining of [[GERD]];
*Do not request [[manometry]] or ambulatory reflux monitoring routinely.
*Do not request [[manometry]] or ambulatory [[GERD]] monitoring routinely.


==References==
==References==

Revision as of 17:51, 27 August 2020

Heartburn Resident Survival Guide Microchapters
Overview
Causes
Diagnosis
Treatment
Do's
Don'ts


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]

Overview

Heartburn is the feeling of burning or pressure inside the chest, normally located behind the breastbone, which can last for several hours and may worsen after food ingestion. Some patients may also have a peculiar acid taste in the back of the throat accompanied with excessive salivation, regurgitating gas and bloating.[1] The most common cause of heartburn is gastroesophageal reflux disease (GERD), in which the lower esophageal sphincter allows for gastric content to reflux into the esophagus. This may cause atypical symptoms which includes: coughing, wheezing or asthma-like symptoms, hoarseness, sore throat, dental erosions or gum disease, discomfort in the ears and nose. Heartburn is a symptom though, and it can have other causes besides GERD, such as esophagitis (infections, eosinophilic) and esophageal cancer. It can also be mistaken by chest pain and presented in life-threatening diseases such as acute coronary syndromes, aortic dissection and pericarditis.

Causes

Life Threatening Causes

Heartburn can be expressed by the patient as a type of chest pain. While evaluating heartburn, it is mandatory to differentiate it from cardiac chest pain.

Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.

Differentiating heartburn from angina [2] [3]
Heartburn (GERD) Angina or Heart Attack
Burning chest pain, begins at the breastbone Tightness, pressure, squeezing, stabbing or dull pain, most often in the center
Pain that radiates towards the throat Pain radiates to the shoulders, neck or arms
Sensation of food coming back to the mouth Irregular or rapid heartbeat
Acid taste in the back of the throat Cold sweat or clammy skin
Pain worsens when patient lie down or bend over Lightheadedness, weakness, dizziness, nausea, indigestion or vomiting
Appears after large or spicy meal Shortness of breath
Symptoms appears with physical exertion or extreme stress

Common Causes

Diagnosis

Below is shown a compendium of information summarizing the diagnosis of gastroesophageal reflux disease (GERD) according the the American Journal of Gastroenterology guidelines.[4]

The diagnosis of GERD is made based on:

  • Symptom presentation;
  • Response to antisecretory therapy;
  • Objective testing with endoscopy;
  • Ambulatory reflux monitoring.[4]


 
 
 
Classic symptoms of GERD
(heartburn and regurgitation)
 
If there are warning signs*:
upper endoscopy during the initial evaluation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PPI 8-week trial
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If better: GERD probable
 
If refractory, proceed to refractory GERD algorithm


* Dysphagia, bleeding, anemia, weight loss and recurrent vomiting are considered warning signs and should be investigated with upper endoscopy.


Shown below is an algorithm summarizing the treatment of refractory GERD according the the American Journal of Gastroenterology guidelines.[4]

 
 
 
 
 
 
Treat GERD:
Start a 8-week course of PPI
 
If there are warning signs*:
upper endoscopy during the initial evaluation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Refractory GERD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Optimize PPI therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No response:
Exclude other etiologies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Typical symptoms:
Upper endoscopy
 
 
 
 
 
Atypical symptoms:
Referral to ENT, pulmonary, allergy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormal:
(eosinophilic esophagitis, erosive esophagitis, other)
Specific treatment
 
NORMAL
 
Abnormal:
(ENT, pulmonary, or allergic disorder)
Specific treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFLUX MONITORING
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low pre test probability of GERD
 
High pre test probability of GERD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test off medication with pH or impedance-pH
 
Test on medication with impedance-pH
 
 
 
 

Perform upper endoscopy to detect esophageal adenocarcinoma and Barret’s esophagus. Surveillance examinations should occur not more frequently than once every 3 to 5 years. If the patient presents with Barret's esophagus or dysplasia, more frequent intervals are indicated. [5]

Screening for H. Pylori is not recommended routinely on GERD. [5]

Diagnostic Testing for GERD [4] [6]
Test Indication Recommendation
Proton Pump Inhibitor (PPI) trial Classic symptoms, no warning/alarm symptoms If negative does not rule out GERD
Barium swallow Use for evaluating dysphagia Only useful for complications (stricture, ring)
Endoscopy Use if alarm symptoms, chest pain or high risk* patients Consider early for elderly, high risk for Barret’s, non-cardiac chest pain, patients unresponsive to PPI
Esophageal biopsy Exclude non-GERD causes
Esophageal manometry Pre operative evaluation for surgery Rule out achalasia/scleroderma-like esophagus pre-op
Ambulatory reflux monitoring Preoperatively for non-erosive disease, refractory GERD symptoms or GERD diagnosis in question Correlate symptoms with reflux, document abnormal acid exposure or reflux frequency

Treatment

Shown below is an algorithm summarizing the treatment of refractory GERD according the the American Journal of Gastroenterology guidelines.[4]

Lifestyle modifications are indicated for all patients and include:

  • Dietary changes (reduce ingestion of chocolate, caffeine, alcohol, acidic and/or spicy foods - low degree of evidence, but there are reports of improvements with elimination);
  • Weight loss for overweight patients or patients that have had recent weight gain;
  • Head of bed elevation and avoidance of meals 2–3 h before bedtime if nocturnal symptoms.[4]
Medications used in GERD
Medication Indication Recommendation
PPI therapy All patients without contraindications Use the lowest effective dose, safe during pregnancy
H2-receptor antagonist May be used as a complement to PPIs or as maintenance option in patients without erosive disease Beware tachyphylaxis after several weeks of usage
Prokinetic therapy and/or baclofen Used if symptoms do not improve Undergo diagnostic evaluation first
Sucralfate Pregnant women No role in non-pregnant patients


Do's

Don'ts

References

  1. "Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management". National Institute for Health and Care Excellence: Clinical Guidelines. 2019. PMID 31935049.
  2. "Heartburn vs. heart attack - Harvard Health".
  3. Bösner S, Haasenritter J, Becker A, Hani MA, Keller H, Sönnichsen AC; et al. (2009). "Heartburn or angina? Differentiating gastrointestinal disease in primary care patients presenting with chest pain: a cross sectional diagnostic study". Int Arch Med. 2: 40. doi:10.1186/1755-7682-2-40. PMC 2799444. PMID 20003376.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Katz PO, Gerson LB, Vela MF (2013). "Guidelines for the diagnosis and management of gastroesophageal reflux disease". Am J Gastroenterol. 108 (3): 308–28, quiz 329. doi:10.1038/ajg.2012.444. PMID 23419381.
  5. 5.0 5.1 "www.worldgastroenterology.org" (PDF).
  6. Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N (2017). "ACG and CAG Clinical Guideline: Management of Dyspepsia". Am J Gastroenterol. 112 (7): 988–1013. doi:10.1038/ajg.2017.154. PMID 28631728.


Template:WikiDoc Sources